Pneumonia in the intensive care unit

Critical Care Medicine

Volumn 31, Issue 10, 2003, Pages 2544-2551

  Rello, Jordi ^a   Diaz, Emili ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; METICILLIN; OXYGEN;

ACINETOBACTER BAUMANNII; CANDIDA; CLINICAL FEATURE; DECISION THEORY; DEVICE; DEVICE REMOVAL; DISEASE COURSE; DRUG CHOICE; DRUG EXPOSURE; HAND WASHING; HEALTH CARE; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFORMATION PROCESSING; INSTITUTIONAL CARE; INTENSIVE CARE; INTUBATION; MEDLINE; MICROBIOLOGICAL EXAMINATION; MICROORGANISM; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PENICILLIN RESISTANCE; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROTECTION; PSEUDOMONAS AERUGINOSA; REVIEW; RISK; SAMPLE; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; VENTILATOR; VIRULENCE;

ADULT; ANTI-BACTERIAL AGENTS; CROSS INFECTION; DECISION TREES; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; PNEUMONIA; RESPIRATION, ARTIFICIAL;

EID: 0142088761     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000089928.84326.D2     Document Type: Review

References (87)

1. Haley RW, Hooton TM, Culver DH, et al: Nosocomial infections in US hospitals, 1975-76: Estimated frequency by selected characteristics of patients. Am J Med 1981; 70:947-959
2. Vincent JL, Bihari DJ, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995; 274:639-644
3. Rello J: Impact of nosocomial infections on outcome: Myths and evidence. Infect Control Hosp Epidemiol 1999; 20:392-394
4. Richards MJ, Edwards JR, Culver DH, et al: Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27:887-892
5. Kollef MH: Ventilator-associated pneumonia: A multivariate analysis. JAMA 1993; 270:1965-1970
6. Rello J, Diaz E, Roque M, et al: Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med 1999; 159:1742-1746
7. National Nosocomial Infections (NNIS) system: Data summary from Jan 1992-June 2001. Am J Infect Control 2001; 29:408-421
8. Heyland DK, Cook DJ, Griffith L, et al: The attributable mortality and mortality of ventilator-associated pneumonia in the critically ill study: The Canadian Clinical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-1256
9. Cook DJ, Walter SD, Cook RJ, et al: Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1988; 129:433-440
10. Rello J, Ollendorf DA, Oster G, et al: Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121
11. th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia - Chicago, Illinois, May 2002. Intensive Care Med 2002; 28:1521-1536
12. Rello J, Rue M, Jubert P, et al: Survival in patients with nosocomial pneumonia: Impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25:1862-1867
13. Rello J, Jubert P, Valles J, et al: Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996; 23:973-978
14. Kollef MH, Silver P, Murphy DM, et al: The effect of late onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662
15. Fagon JY, Chastre J, Hance AJ, et al: Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
16. Rello J, Torres A, Ricart M, et al: Ventilator-associated pneumonia by Staphylococcus aureus: Comparison of methicillin-resistant with methicillin sensitive episodes. Am J Respir Crit Care Med 1994; 150:1545-1549
17. Pinner RW, Haley RW, Blumenstein BA, et al: High cost of nosocomial pneumonia. Infect Control 1982; 3:143-149
18. Beyt BE Jr, Troxler S, Cavaness J: Prospective payment and infection control. Infect Control 1985; 6:161-164
19. Dreyfuss D, Djedaini K, Gros I, et al: Mechanical ventilation with heated humidifiers and head moisture exchangers: Effects on patient colonization and incidence of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 151:986-992
20. Torres A, Serra-Batlles J, Ros E, et al: Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position. Ann Intern Med 1992; 116:540-543
21. Orozco-Levi M, Torres A, Ferrer M, et al: Semi-recumbent position protect from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 1995; 152:1387-1390
22. Vallés J, Artigas A, Rello J, et al: Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122:229-231
23. Rumbak MJ: Ventilator-associated pneumonia. J Respir Dis 2000; 21:321-327
24. Ricart M: Management of airways in intubated patients. Clin Pulm Med 1997; 4:148-151
25. Rello J, Soñora R, Jubert P, et al: Pneumonia in intubated patients: Role of respiratory airway care. Am J Respir Crit Care Med 1996; 154:111-115
26. Olson ME, Harmon BG, Kollef MH: Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest 2002; 121:863-870
27. Kollef MH: The prevention of ventilator-associated pneumonia: An evidence-based approach. N Engl J Med 1999; 340:627-634
28. Rello J, Lorente C, Bodi M, et al: Why do physicians not follow evidence-based guidelines preventing ventilator-associated pneumonia? A survey based on the opinions of an international panel of intensivists. Chest 2002; 122:656-661
29. Ricart M, Lorente C, Diaz E, et al: Nursing adherence in prevention of ventilator-associated pneumonia. Crit Care Med, In Press
30. Zack JE, Garrison T, Trovillion E, et al: Effect of a hospital-wide education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002; 30:2407-2412
31. Rello J: Changing physicians' behavior in the intensive care unit. Crit Care Med 2002; 30:2593
32. American Thoracic Society: Hospital-acquired pneumonia in ventilated patients. Diagnosis, assessment of severity, initial antimicrobial therapy and preventative strategies. Am J Respir Crit Care Med 1995; 153:1711-1725
33. Trouillet JL, Chastre J, Vuagnat A, et al: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
34. Rello J, Sa-Borges M, Correa H, et al: Variations in etiology of ventilator-associated pneumonia around four treatment sites: Implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613
35. Namias J, Samiian L, Nino D, et al: Incidence and susceptibility of pathogenic bacteria vary between ICU within a single hospital: Implications for empiric antibiotic strategies. J Trauma 2000; 49:638-645
36. Ibrahim EH, Ward S, Shernan G, et al: A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117:1434-1442
37. Pujol M, Corbella X, Peña C, et al: Clinical and epidemiologic findings in mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur J Clin Microbiol Infect Dis 1998; 17:622-628
38. Rello J, Ausina V, Ricart M, et al: Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235
39. Rello J, Esandi ME, Diaz E, et al: The role of Candida spp. isolated from bronchoscopic samples in nonneutropenic patients. Chest 1998; 114:146-149
40. El-Ebiary M, Torres A, Fabregas N, et al: Significance of the isolation of Candida species from respiratory samples in critically ill non-neutropenic patients. Am J Respir Crit Care Med 1997; 156:583-590
41. Rello J, Mariscal D, Gallego M, et al: Effect of thioglycolate as transport medium in the direct examination of respiratory samples and guiding initial antibiotic treatment in intubated patients with pneumonia. Crit Care Med 2002; 30:310-314
42. Roig J, Rello J: Legionnaires' disease: A rational approach to therapy. J Antimicrob Chemother 2003; 51:1119-1129
43. Papazian L, Fraisse A, Garbe L, et al: Cytomegalovirus: An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84:280-287
44. Gallego M, Rello J: Diagnostic testing for ventilator-associated pneumonia. Clin Chest Med 1999; 20:671-679
45. Wunderink RG, Woldenberg LS, Zeiss J, et al: The radiologic diagnosis of autopsy proven ventilator-associated pneumonia. Chest 1992; 101:458-463
46. Meduri GU, Mauldin GL, Wunderink RG, et al: Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106:221-235
47. Singh N, Rogers P, Atwood CW, et al: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511
48. Pugin J, Auckentaler R, Mili N, et al: Diagnosis of ventilator- associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-1129
49. Luna CM, Blanzaco D, Niederman M, et al: Resolution of ventilator-associated pneumonia: A prospective evaluation of early clinical predictors of outcome. Crit Care Med 2002; 31:676-682
50. Chastre J, Fajon JY, Soler P, et al: Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: Comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1998; 84:499-506
51. Morris AJ, David CT, Reller LB: Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol 1993; 31:1027-1029
52. Mertens AH, Nagler JM, Galdermans DI, et al: Quality assessment of protected specimen brush samples by microscopic cell count. Am J Respir Crit Care Med 1998; 1240-1243
53. Salata RA, Lederman MM, Shlaes DM, et al: Diagnosis of nosocomial pneumonia in intubated intensive care unit patients. Am Rev Respir Dis 1987; 135:426-432
54. Rello J, Paiva A, Baraibar J, et al: International conference for the development of consensus on the diagnosis and treatment of ventilator- associated pneumonia. Chest 2001; 120:955-970
55. Fagon JY, Chastre J, Wolff M, et al: Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: A randomized trial. Ann Intern Med 2000; 132:621-630
56. Gallego M, Vallés J, Rello J: New perspectives in the diagnosis of ventilator-associated pneumonia. Curr Opin Pulm Med 1997; 23:116-119
57. Luna CM, Vujacich P, Niederman MS, et al: Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
58. Rello J, Gallego M, Mariscal D, et al: The value of routine microbiological investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:196-200
59. Iregui M, Ward S, Sherman G, et al: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268
60. Hoyt J, McKibben A, Schmitz L, et al: Effect of mechanical ventilation strategy on dissemination of E. coli pneumonia in dogs. Crit Care Med 1997; 25:1733-1743
61. Verbrugge SL, Sorm V, van't Veen A, et al: Lung overinflation without positive end-expiratory pressure promote bacteremia after experimental Klebsiella pneumoniae inoculation. Intensive Care Med 1998; 24:172-177
62. Kollef MH, Ward S: The influence of mini-BAL cultures on patient outcome: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412-420
63. Alvarez-Lerma F: Modification of empiric antibiotic therapy in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996; 22:387-394
64. Dupont H, Mentec H, Sollet JP, et al: Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27:355-362
65. Höffken G, Niederman MS: Nosocomial pneumonia: The importance of a de-escalation strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122:2183-2196
66. Kollef MH: Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 2001; 29:1473-1474
67. Rello J, Diaz E: Optimal use of antibiotics for intubation-associated pneumonia. Intensive Care Med 2001; 27:337-339
68. Sandiumenge A, Diaz E, Bodi M, et al: Treatment of ventilator-associated pneumonia: A patient-based approach based on the rules of "the Tarragona strategy." Intensive Care Med 2003; 29:876-883
69. Gruson D, Hilbert G, Vargas F, et al: Rotation and restricted use of antibiotics in a medical intensive care unit. Am J Respir Crit Care 2000; 162:837-843
70. Raymond DP, Pelletier SJ, Crabree TD, et al: Impact of rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001; 29:1101-1108
71. Rello J, Mariscal D, March F, et al: Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: Relapse or reinfection? Am J Respir Crit Care Med 1998; 157:912-916
72. Gonzalez C, Rubio M, Romero-Vivas J, et al: Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 1999; 29:1171-1177
73. Cammarata SK, Hempsall KA, Oliphant T: Linezolid in nosocomial pneumonia: Efficacy results by severity of illness as determined by APACHE II scores. Chest 2001; 120(Suppl):168S
74. Wunderink RG, Rello J, Cammarata SK, et al: Linezolid versus vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest, In Press
75. Lamer C, de Beco V, Soler P, et al: Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 1993; 37:281-286
76. Montero A, Ariza J, Corbella X, et al: Efficacy of colistin in betalactams, aminoglycosides and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother 2002; 46:1946-1952
77. Schentag JJ: Antimicrobial management strategies for Gram-positive bacterial resistance in the intensive care unit. Crit Care Med 2001; 29:100-107
78. Hauser AR, Cobb E, Bodi M, et al: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 2002; 30:521-528
79. Schulert GS, Feltman H, Rabin SDP, et al: Secretion of the toxin exoU is a marker for highly virulent Pseudomonas aeruginosa isolates from patients with hospital-acquired pneumonia. J Infect Dis, In Press
80. 79a. Jones RN, Deshpande LM, Mutnick AH, et al: In vitro evaluation of BAL 9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci. JAC 2002; 50:915-932
81. Sawa T, Yahr T, Ohara M, et al: Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999; 5:392-398
82. Doebbeling BN, Stanley GL, Sheetz CT, et al: Comparative efficacy of alternative handwashing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327:88-93
83. Bonten MJM, Kullberg BJ, Dalen RV, et al: Selective digestive decontamination in patients in intensive care. J Antimicrob Chemother 2000; 46:351-362
84. Montecalvo MA, Steger KA, Farber HW, et al: Nutritional outcome and pneumonia in critical care patients randomized to gastric versus jejunal tube feedings. Crit Care Med 1992; 20:281-288
85. Cook DJ, De Jonghe B, Heyland DK: The relation between nutrition and nosocomial pneumonia: Randomized trials in critically ill patients. Crit Care Med 2001; 29:1916-1919
86. Lorente C, del Castillo Y, Rello J: Prevention of infections in the ICU. Curr Opinion Crit Care Med 2002; 23:461-464
87. Collard HR, Saint S, Matthay MA: Prevention of ventilator-associated pneumonia: An evidence-based systematic review. Ann Intern Med 2003; 138:494-501